Single nucleotide polymorphisms of RecQ1, RAD54L, and ATM genes are associated with reduced survival of pancreatic cancer

Journal of Clinical Oncology

Volumn 24, Issue 11, 2006, Pages 1720-1728

  Li, Donghui ^a   Frazier, Marsha ^a   Evans, Douglas B ^a   Hess, Kenneth R ^a   Crane, Christopher H ^a   Jiao, Li ^a   Abbruzzese, James L ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; CISPLATIN; DNA BINDING PROTEIN; GEMCITABINE; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; PROTEIN LIG4; PROTEIN XRCC1; PROTEIN XRCC2; PROTEIN XRCC3; RAD54 PROTEIN; RECQ HELICASE; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; ADENOSINE TRIPHOSPHATASE; ANTINEOPLASTIC ANTIMETABOLITE; CELL CYCLE PROTEIN; DEOXYCYTIDINE; DRUG DERIVATIVE; HELICASE; NUCLEAR PROTEIN; PROTEIN SERINE THREONINE KINASE; RAD54L PROTEIN, HUMAN; RECQL PROTEIN, HUMAN; TUMOR SUPPRESSOR PROTEIN;

ADULT; AGED; ALLELE; ARTICLE; CANCER GROWTH; CANCER RISK; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROGNOSIS; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT RESPONSE; GENETICS; MIDDLE AGED; MORTALITY; PANCREAS TUMOR;

ADENOSINE TRIPHOSPHATASES; ADULT; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; CELL CYCLE PROTEINS; DEOXYCYTIDINE; DNA HELICASES; DNA REPAIR; DNA-BINDING PROTEINS; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NUCLEAR PROTEINS; PANCREATIC NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN-SERINE-THREONINE KINASES; RECQ HELICASES; TUMOR SUPPRESSOR PROTEINS;

EID: 33645814832     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.04.4206     Document Type: Article

References (34)

1. Greenlee RT, Murray T, Bolden S, et al: Cancer statistics 2000. CA Cancer J Clin 50:7-33, 2000
2. Cleary SP, Gryfe R, Guindi M, et al: Prognostic factors in resected pancreatic adenocarcinoma: Analysis of actual 5-year survivors. J Am Col Surg 198:722-731, 2004
3. Bardeesy N, DePinho RA: Pancreatic cancer biology and genetics. Nat Rev Cancer 2:897-909, 2002
4. Phillips KA, Van Bebber SL: Measuring the value of pharmacogenomics. Nat Rev Drug Discov 4:500-509, 2005
5. Burris HA III, Moore MJ, Andersen J, et al: Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: A randomized trial. J Clin Oncol 15:2403-2413, 1997
6. Crul M, van Waardenburg RC, Bocxe S, et al: DNA repair mechanisms involved in gemcitabine cytotoxicity and in the interaction between gemcitabine and cisplatin. Biochem Pharmacol 65:275-282, 2003
7. Wachters FM, van Putten JW, Maring JG, et al: Selective targeting of homologous DNA recombination repair by gemcitabine. Int J Radiat Oncol Biol Phys 57:553-562, 2003
8. Shenouda G: Strand-break repair and radiation resistance, in Panasci LC, Alaoui-Jamali MA (eds): DNA Repair in Cancer Therapy. Totowa, NJ, Humana Press, 2004, pp 257-272
9. Peterson CL, Cote J: Cellular machineries for chromosomal DNA repair. Genes Dev 18:602-616, 2004
10. Bosken CH, Wei Q, Amos CI, et al: An analysis of DNA repair as a determinant of survival in patients with non-small-cell lung cancer. J Natl Cancer Inst 94:1091-1099, 2002
11. Camps C, Sarries C, Roig B, et al: Assessment of nucleotide excision repair XPD polymorphisms in the peripheral blood of gemcitabine/cisplatin- treated advanced non-small-cell lung cancer patients. Clin Lung Cancer 4:237-241, 2003
12. Park DJ, Stoehlmacher J, Zhang W, et al: Xeroderma pigmentosum group D gene polymorphism predicts clinical outcome to platinum-based chemotherapy in patients with advanced colorectal cancer. Cancer Res 61:8654-8658, 2001
13. Gurubhagavatula S, Liu G, Park S, et al: XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small-cell lung cancer patients treated with platinum chemotherapy. J Clin Oncol 22:2594-2601, 2004
14. Greene FL, Page DL, Fleming ID, et al: Exocrine pancreas, in AJCC Cancer Staging Manual. New York, Springer, 2002, pp 157-164
15. Evans DB, Rich TA, Byrd DR, et al: Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas. Arch Surg 127:1335-1339, 1992
16. Kaneko H, Fukao T, Kondo N: The function of RecQ helicase gene family (especially BLM) in DNA recombination and joining. Adv Biophys 38:45-64, 2004
17. Khakhar RR, Cobb JA, Bjergbaek L, et al: RecQ helicases: Multiple roles in genome maintenance. Trends Cell Biol 13(9):493-501, 2003
18. Hickson ID: RecQ helicases: Caretakers of the genome. Nat Rev Cancer 3:169-178, 2003
19. Mohaghegh P, Hickson ID: DNA helicase deficiencies associated with cancer predisposition and premature ageing disorders. Hum Mol Genet 10:741-746, 2001
20. Cui S, Arosio D, Doherty KM, et al: Analysis of the unwinding activity of the dimeric RECQ1 helicase in the presence of human replication protein A. Nucleic Acids Res 32:2158-2170, 2004
21. Sharma S, Sommers JA, Choudhary S, et al: Biochemical analysis of the DNA unwinding and strand annealing activities catalyzed by human RECQ1. J Biol Chem 280:28072-28084, 2005
22. Doherty KM, Sharma S, Uzdilla LA, et al: RECQ1 helicase interacts with human mismatch repair factors that regulate genetic recombination. J Biol Chem 280:28085-28094, 2005
23. Rasio D, Murakumo Y, Robbins D, et al: Characterization of the human homologue of RAD54: A gene located on chromosome 1 p32 at a region of high loss of heterozygosity in breast tumors. Cancer Res 57:2378-2383, 1997
24. Matsuda M, Miyagawa K, Takahashi M, et al: Mutations in the RAD54 recombination gene in primary cancers. Oncogene 18:3427-3430, 1999
25. Leone PE, Mendiola M, Alonso J, et al: Implications of a RAD54L polymorphism (2290C/T) in human meningiomas as a risk factor and/or a genetic marker. BMC Cancer 3:6, 2003
26. Golding SE, Rosenberg E, Khalil A, et al: Double strand break repair by homologous recombination is regulated by cell cycle-independent signaling via ATM in human glioma cells. J Biol Chem 279:15402-15410, 2004
27. Shiloh Y: ATM and related protein kinases: Safeguarding genome integrity. Nat Rev Cancer 3:155-168, 2003
28. Gutierrez-Enriquez S, Fernet M, Dork T, et al: Functional consequences of ATM sequence variants for chromosomal radiosensitivity. Genes Chromosomes Cancer 40:109-119, 2004
29. Angele S, Romestaing P, Moullan N, et al: ATM haplotypes and cellular response to DNA damage: Association with breast cancer risk and clinical radiosensitivity. Cancer Res 63:8717-8725, 2003
30. Caldecott KW, McKeown CK, Tucker JD, et al: An interaction between the mammalian DNA repair protein XRCC1 and DNA ligase III. Mol Cell Biol 14:68-76, 1994
31. Cappelli E, Taylor R, Cevasco M, et al: Involvement of XRCC1 and DNA ligase III gene products in DNA base excision repair. J Biol Chem 272:23970-23975, 1997
32. Goode EL, Ulrich CM, Potter JD: Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev 11:1513-1530, 2003
33. Audebert M, Salles B, Calsou P: Involvement of poly(ADP-ribose) polymerase-1 and XRCC1/DNA ligase III in an alternative route for DNA double-strand breaks rejoining. J Biol Chem 279:55117-55126, 2004
34. Wang H, Rosidi B, Perrault R, et al: DNA ligase III as a candidate component of backup pathways of nonhomologous end joining. Cancer Res 65:4020-4030, 2005